CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 71 enrolled
Drug / intervention
Puregraft System +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02503852
NCT02503852N/ACompleted

Subcutaneous Transplantation of Autologous Cell Enriched Adipose Tissue For Follicular Niche Stimulation in Early Stage Alopecia Androgenetica (STYLE): a Randomized, Blinded, Controlled Trial

Kerastem Technologies, LLC·interventional·Posted Jul 21, 2015·Updated Jan 13, 2020

In Brief

A clinical study evaluating Puregraft System, Celution System, and 2 other interventions for Alopecia, Androgenetic. Completed, enrolled 71 participants across 4 sites.

Detailed Summary

The primary objective of this study is to evaluate the safety and feasibility of the Celution and Puregraft Systems in the processing and preparation of an autologous fat graft enriched with adipose-derived regenerative cells (ADRCs) in the treatment of early alopecia androgenetica.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 21, 2015
Enrollment StartNov 1, 2015
Primary CompletionMar 2, 2018
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 10.9 years ago

Interventions

Puregraft Systemdevice

The Puregraft System prepares purified adipose tissue for subcutaneous scalp injection.

Celution Systemdevice

The Celution System prepares adipose derived regenerative cells (ADRCs) for subcutaneous scalp injection.

Kerastem Therapyprocedure

The Kerastem Therapy is the subcutaneous scalp injection of purified adipose prepared with the Puregraft System enriched with ADRCs prepared from the Celution System.

Liposuctionprocedure

Tissue collection involving the micro-harvest of subcutaneous adipose tissue.